IGMS
IGM Biosciences
IGMS
IGMS
Delisted
IGMS was delisted on the 13th of August, 2025.
80 hedge funds and large institutions have $20.5M invested in IGM Biosciences in 2025 Q1 according to their latest regulatory filings, with 21 funds opening new positions, 21 increasing their positions, 26 reducing their positions, and 23 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
less funds holding
Funds holding: →
11.8% less ownership
Funds ownership: 63.61% → 51.82% (-12%)
19% less repeat investments, than reductions
Existing positions increased: 21 | Existing positions reduced: 26
85% less capital invested
Capital invested by funds: $133M → $20.5M (-$112M)
Holders
80
Holding in Top 10
1
Calls
$32K
Puts
$1K
Top Buyers
| 1 | +$382K | |
| 2 | +$275K | |
| 3 | +$137K | |
| 4 |
Two Sigma Advisers
New York
|
+$104K |
| 5 |
Acadian Asset Management
Boston,
Massachusetts
|
+$97K |
Top Sellers
| 1 | -$4.11M | |
| 2 | -$1M | |
| 3 | -$770K | |
| 4 |
Wellington Management Group
Boston,
Massachusetts
|
-$617K |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
-$538K |
